197 related articles for article (PubMed ID: 32564760)
1. Digitizing the Pharma Neurons - A Technological Operation in Progress!
Bhardwaj P; Yadav RK; Kurian S
Rev Recent Clin Trials; 2020; 15(3):178-187. PubMed ID: 32564760
[TBL] [Abstract][Full Text] [Related]
2. Advancing pharmacy and healthcare with virtual digital technologies.
Trenfield SJ; Awad A; McCoubrey LE; Elbadawi M; Goyanes A; Gaisford S; Basit AW
Adv Drug Deliv Rev; 2022 Mar; 182():114098. PubMed ID: 34998901
[TBL] [Abstract][Full Text] [Related]
3. Disruptive innovations in the clinical laboratory: catching the wave of precision diagnostics.
Khatab Z; Yousef GM
Crit Rev Clin Lab Sci; 2021 Dec; 58(8):546-562. PubMed ID: 34297653
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. Big Techs and startups in pharmaceutical R&D - A 2020 perspective on artificial intelligence.
Schuhmacher A; Gatto A; Kuss M; Gassmann O; Hinder M
Drug Discov Today; 2021 Oct; 26(10):2226-2231. PubMed ID: 33965571
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine.
Ahmed Z; Mohamed K; Zeeshan S; Dong X
Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32185396
[TBL] [Abstract][Full Text] [Related]
7. How artificial intelligence is changing drug discovery.
Fleming N
Nature; 2018 May; 557(7707):S55-S57. PubMed ID: 29849160
[No Abstract] [Full Text] [Related]
8. Towards Pharma 4.0 in clinical trials: A future-orientated perspective.
Hariry RE; Barenji RV; Paradkar A
Drug Discov Today; 2022 Jan; 27(1):315-325. PubMed ID: 34537331
[TBL] [Abstract][Full Text] [Related]
9. AI/ML in Precision Medicine: A Look Beyond the Hype.
Xu Z; Biswas B; Li L; Amzal B
Ther Innov Regul Sci; 2023 Sep; 57(5):957-962. PubMed ID: 37310669
[TBL] [Abstract][Full Text] [Related]
10. Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine.
Tsimberidou AM; Ringborg U; Schilsky RL
Am Soc Clin Oncol Educ Book; 2013; ():118-25. PubMed ID: 23714475
[TBL] [Abstract][Full Text] [Related]
11. Precision medicine in oncology drug development: a pharma perspective.
Hollingsworth SJ
Drug Discov Today; 2015 Dec; 20(12):1455-63. PubMed ID: 26482740
[TBL] [Abstract][Full Text] [Related]
12. The rise of micropharma.
Barden CJ; Weaver DF
Drug Discov Today; 2010 Feb; 15(3-4):84-7. PubMed ID: 19837185
[TBL] [Abstract][Full Text] [Related]
13. Success stories of AI in drug discovery - where do things stand?
Mak KK; Balijepalli MK; Pichika MR
Expert Opin Drug Discov; 2022 Jan; 17(1):79-92. PubMed ID: 34553659
[TBL] [Abstract][Full Text] [Related]
14. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
Scattereggia J
IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
[TBL] [Abstract][Full Text] [Related]
15. Are academic drug discovery efforts receiving more recognition with declining industry efficiency?
Bryans JS; Kettleborough CA; Solari R
Expert Opin Drug Discov; 2019 Jul; 14(7):605-607. PubMed ID: 30907161
[No Abstract] [Full Text] [Related]
16. Toward precision health: applying artificial intelligence analytics to digital health biometric datasets.
Cohoon TJ; Bhavnani SP
Per Med; 2020 Jul; 17(4):307-316. PubMed ID: 32588726
[TBL] [Abstract][Full Text] [Related]
17. Melding regulatory, pharmaceutical industry, and U.S. payer perspectives on improving approaches to heterogeneity of treatment effect in research and practice.
Willke RJ; Crown W; Del Aguila M; Cziraky MJ; Khan ZM; Migliori R
Value Health; 2013; 16(6 Suppl):S10-5. PubMed ID: 24034306
[TBL] [Abstract][Full Text] [Related]
18. Data mining in pharma sector: benefits.
Ranjan J
Int J Health Care Qual Assur; 2009; 22(1):82-92. PubMed ID: 19284173
[TBL] [Abstract][Full Text] [Related]
19. Leading a Digital Transformation in the Pharmaceutical Industry: Reimagining the Way We Work in Global Drug Development.
Finelli LA; Narasimhan V
Clin Pharmacol Ther; 2020 Oct; 108(4):756-761. PubMed ID: 32294230
[TBL] [Abstract][Full Text] [Related]
20. Powered by Open Innovation: Opportunities and Challenges in the Pharma Sector.
Martinez-Grau MA; Alvim-Gaston M
Pharmaceut Med; 2019 Jun; 33(3):193-198. PubMed ID: 31933287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
